Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

Conditions

• Incurable Disease

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Not accepted

Interventions

• Evolutionary Tumor Board (ETB) — OTHER
  The ETB consists of evolutionary biologists, mathematicians, research scientists, statisticians,data scientists, radiologists, pathologists, oncologists (surgical, radiation, medical, and pediatric), and clinical trial coordinators.The ETB will generate hypotheses, mathematical models, and experiments from the discussion towards further integration of evolutionary ideas towards therapeutic strategies for participants. The ETB will collect data through a chart review regarding adherence and results of ETB recommendation

Study Details

This study will evaluate the ability of a multidisciplinary group, the Evolutionary Tumor Board (ETB), to develop therapeutic strategies in patients without curative options.

Key Dates

Start date

May 5, 2020

Status verified

Mar 2026

Primary completion

Mar 31, 2028

Completion

Mar 31, 2028

Study Design

Enrollment

35 participants (estimated)

Arms

• Arm: Participants Reviewed by ETB
  Participants clinical history, available therapeutic options, and outcome expectations will be presented to the Evolutionary Tumor Board (ETB) along with images and pathology. Strategies and models will be presented regarding additional evolutionary ideas that can be applied.

Primary Outcome Measure

ETB developing therapeutic strategies [ Time Frame: Baseline to up to 60 months from end of therapy ]

Central Contacts

• Sara Donadelli
  813-745-8111
  [email protected]

Locations (1)

Find similar trials in Tampa, FL